Avanos Medical AVNS Payments for Repurchase of Common Stock
Payments for Repurchase of Common Stock at other companies
Other financials
Where this comes from
Reported directly by Avanos Medical in its filing.
Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.
The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avanos Medical's payments for repurchase of common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Avanos Medical's payments for repurchase of common stock?
- Avanos Medical (AVNS) reported payments for repurchase of common stock of $1.3M in Q1 2026.
- How has Avanos Medical's payments for repurchase of common stock changed year-over-year?
- Avanos Medical's payments for repurchase of common stock decreased by 40.9% year-over-year, from $2.2M to $1.3M.
- What is the long-term trend for Avanos Medical's payments for repurchase of common stock?
- Over 4 years (2021 to 2025), Avanos Medical's payments for repurchase of common stock has grown at a -26.8% compound annual growth rate (CAGR), from $11.5M to $3.3M.
- What does payments for repurchase of common stock mean?
- Captures the cash spent by the company to buy back its own shares from the open market. This is a key indicator of capital allocation strategy, often used to return value to shareholders or offset dilution from equity compensation.